At close: December 24 at 2:00:02 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 3 | 6 | 6 |
| Avg. Estimate | 20.42M | 11.04M | 52.07M | 63.92M |
| Low Estimate | 2.89M | 2.89M | 34.66M | 11.55M |
| High Estimate | 77.05M | 19.5M | 109.46M | 158.83M |
| Year Ago Sales | 1.86M | 5.97M | 8.58M | 52.07M |
| Sales Growth (year/est) | 999.20% | 84.71% | 506.92% | 22.75% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALCLS.PA | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
DBV.PA DBV Technologies S.A.
0.6190
-1.28%
GNFT.PA Genfit S.A.
3.4800
+0.29%
NANO.PA Nanobiotix S.A.
2.9900
-0.27%
MEIP MEI Pharma, Inc.
2.3600
0.00%
CRGX CARGO Therapeutics, Inc.
14.66
-0.41%
VLA.PA Valneva SE
1.9860
+3.76%
ONVO Organovo Holdings, Inc.
0.3402
-1.45%
ACLX Arcellx, Inc.
77.58
+1.03%
MBRX Moleculin Biotech, Inc.
1.8200
+5.20%
FATE Fate Therapeutics, Inc.
1.6600
0.00%